Latest News

VIVOLTA enters Rise program

15 September 2021
After a rigorous selection procedure, VIVOLTA has been selected by as one of the ten scale-up companies to enter the Rise program dedicated to MedTech. As part of the program, VIVOLTA will have access to a community of investors, media and corporates helping it to reach its full potential. Furthermore, VIVOLTA will be supported and advised by scale-up experts and learn from fellow program entrepreneurs in the Rise program. [read more]

IME Medical Electrospinning announces name change to VIVOLTA

07 September 2021
VIVOLTA, a global leader in nanofiber-based medical devices, today announced that it has changed its corporate name from IME Medical Electrospinning to VIVOLTA. [read more]

VIVOLTA co-author of ASTM Standard

26 May 2021
VIVOLTA announced the publication of the first standard for fiber-based medical scaffolds, published by international standards organization ASTM. The standard was co-authored by VIVOLTA’s CTO Ramon Solberg and will guide the design and manufacture of fiber-based medical products… [read more]

New collaboration VIVOLTA & STENTiT

09 February 2021
VIVOLTA has entered into a collaboration with Dutch medical device company STENTiT, to join forces in the further development and production of regenerative endovascular support grafts. These resorbable fibrous implants hold the promise to rebuild a new blood vessel inside the existing artery, by exploiting the natural healing response of the body. [read more]

VIVOLTA is Challenger50 of 2020

11 November 2020
VIVOLTA has been nominated as one of the 50 most innovative and fast growing Dutch companies of 2020 by Sprout. We are extremely grateful for this recognition and strive to keep growing and innovating. [read more]

VIVOLTA secured € 3 mln in new financing

13 September 2020
VIVOLTA, a global leader in electrospun medical devices and regenerative medicine, today announced it has successfully raised €3 million in equity financing and debt from existing shareholder TIIN Capital, new investors Borski Fund and Lumana Invest, and from Rabobank Region Eindhoven. [read more]